<?xml version="1.0" encoding="utf-8"?>
<DATASETS>
	<DATASET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" alias="ESAD-UK_PCAWG_WGS_BWA" center_name="ICGC" broker_name="EGA" accession="EGAD00001002156">
		<TITLE>ICGC PCAWG Dataset: ESAD-UK_PCAWG_WGS_BWA</TITLE>
		<DESCRIPTION>ICGC PCAWG Dataset for WGS BAM aligned using BWA MEM. Project: ESAD-UK.</DESCRIPTION>
		<ANALYSIS_REF accession="EGAZ00001230146"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230324"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230216"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230176"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230340"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230337"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230343"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230257"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230321"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230215"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230190"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230148"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230336"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230296"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230209"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230271"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230250"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230153"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230274"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230341"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230163"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230204"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230288"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230326"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230229"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230299"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230280"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230276"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230259"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230158"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230167"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230234"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230290"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230164"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230315"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230245"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230186"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230253"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230272"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230333"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230300"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230237"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230235"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230318"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230179"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230184"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230177"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230314"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230292"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230152"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230168"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230232"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230291"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230303"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230198"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230249"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230241"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230175"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230310"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230224"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230205"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230230"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230338"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230196"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230264"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230159"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230236"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230312"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230277"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230166"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230149"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230233"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230335"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230161"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230193"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230183"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230219"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230206"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230342"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230267"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230256"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230155"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230147"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230188"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230211"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230217"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230238"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230178"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230225"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230294"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230319"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230181"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230284"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230306"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230192"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230200"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230252"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230218"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230313"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230298"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230339"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230248"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230221"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230251"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230247"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230327"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230223"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230260"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230254"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230195"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230266"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230222"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230202"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230226"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230231"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230191"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230295"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230301"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230227"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230279"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230281"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230285"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230151"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230194"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230201"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230305"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230213"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230172"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230255"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230214"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230317"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230239"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230263"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230169"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230170"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230244"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230283"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230304"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230154"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230162"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230220"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230316"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230173"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230203"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230187"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230160"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230240"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230150"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230212"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230270"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230165"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230320"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230287"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230157"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230243"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230308"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230309"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230334"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230282"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230180"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230273"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230329"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230268"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230330"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230242"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230328"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230325"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230297"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230258"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230208"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230228"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230261"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230302"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230199"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230182"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230269"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230265"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230262"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230207"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230289"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230286"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230197"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230323"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230246"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230311"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230189"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230174"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230293"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230307"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230156"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230185"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230278"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230332"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230210"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230171"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230275"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230322"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001230331"></ANALYSIS_REF>
		<POLICY_REF accession="EGAP00001000011" refname="ICGC Data Access Agreements" refcenter="ICGC">
			<IDENTIFIERS>
				<PRIMARY_ID>EGAP00001000011</PRIMARY_ID>
				<SUBMITTER_ID namespace="ICGC">ICGC Data Access Agreements</SUBMITTER_ID>
			</IDENTIFIERS>
		</POLICY_REF>
		<DATASET_LINKS>
			<DATASET_LINK>
				<URL_LINK>
					<LABEL>ICGC Data Portal</LABEL>
					<URL>http://dcc.icgc.org</URL>
				</URL_LINK>
			</DATASET_LINK>
		</DATASET_LINKS>
	</DATASET>
</DATASETS>